URL copied
File photo: Congress MP Manish Tewari speaks in the Lok Sabha. (Representational image)
At a time when vaccine distribution to states across India is in full swing ahead of the January 16 launch, the Congress party has raised questions on the safety, compatibility of India s homegrown Covid vaccine named COVAXIN, asking the government how it can be rolled out when it is yet to clear phase-3 trials. Congress MP Manish Tewari has upped the issue saying Indians are not guinea pigs (someone who is used for an experiment), raising doubts on Bharat Biotech s vaccine efficacy.
Congress has cautioned the government that since the Covaxin vaccine has not completed phase-3 trials, it should not be rolled out as Indians are not guinea pigs .
Myanmar’s Migrants Face Discrimination Amid Surging COVID-19 in Thailand
Myanmar embassy officials led by Minister-Counselor U Maw Ba La arranges to transfer the Myanmar migrants–who tested COVID-19 positive and were quarantined previously at home–to the temporary field hospital in Mahachai’s football ground on January 8, 2021. / Myanmar Labour Attaché Office / Facebook
3.3k
By Nyein Nyein 9 January 2021
Less than a month after Thailand’s leaders blamed Myanmar migrant workers for the latest COVID-19 outbreak in Samut Sakhon’s wholesale seafood market, discrimination has become a part of Myanmar migrants’ daily lives in everything from transportation to banking.
Ever since Dec. 17 when a 67-year-old Thai vendor working in Mahachai’s shrimp wholesale market tested positive for COVID-19, the market, where many Myanmar migrants work, has been in lockdown. In news reports over the following days, Thailand’s health minister and then prime minister accused illega
Measures tightened in 5 areas
19
Only essential travel allowed from now on
published : 7 Jan 2021 at 04:00
19 Food and Drug Administration and Royal Thai Police officers raid two warehouses in Nong Khaem district, Bangkok, on Wednesday after hearing they were being used to store used rubber gloves amid the coronavirus pandemic. Officers found 200 million baht worth of used gloves - some of which had already been washed and were ready to be resold - in the raid. An investigation is underway to find out who imported the gloves. (Photo: Pattarapong Chatpattarasill)
The government on Wednesday tightened Covid-19 control measures in the country s most at-risk provinces, with an emphasis on screening people leaving and entering them.
Updated:
Covaxin works on the whole of the virus even with mutations, says Dr. Paul.
Share Article
AAA
World Health Organisation and UNICEF officials inspect a COVID-19 vaccination dry run camp at a primary health centre in Ekkattuthangal, Chennai on January 2, 2020. | Photo Credit:
Velankanni Raj B
Covaxin works on the whole of the virus even with mutations, says Dr. Paul.
India should be able to roll out its COVID-19 vaccination programme in the “near future” as its preparation is ready and robust, NITI Aayog member (health) V.K. Paul said in an exclusive interview with
The Hindu, adding that at least 12 countries have specified their interest in India’s indigenous COVID-19 vaccine, Covaxin.
Representative image
India moving towards herd immunity as COVID-19 cases declining, no need to panic over UK virus strain: Health experts ANI | Updated: Jan 01, 2021 04:12 IST
New Delhi [India], December 31 (ANI): India is perhaps moving towards herd immunity as COVID-19 cases are declining and there is no need to panic over the new virus strain found in the United Kingdom because reports suggest that it not as virulent, doctors said at a webinar on Thursday.
The webinar HEAL-Thy Samvaad was organised by the Heal Foundation to discuss the dynamics of the new strain of COVID-19 detected first in the UK.
According to the union health ministry, about 25 people in India have been diagnosed with the UK variant strain of COVID-19. All 25 persons are in physical isolation in health facilities.